Skip to content

CABA - Cabaletta Bio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Cabaletta Bio Inc

CABA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CABACabaletta Bio Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $4.23
52-wk low: $1.40
Prev close: $2.96
Mkt cap: $525.6M
Beta: 3.25
P/B: 2.3x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$93.7M

CI
Citadel
Ken Griffin · Q2 2026 13F
$11.0M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 8.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $526M

Valuation

P/B2.33

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CABA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $525.59M
Beta: 3.25

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-93.2%

$6.4M

position

MW

Marshall Wace

Q2 2026 13F

$4.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CABA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.34+8.1%

-$0.37 expected

Next report

What the street expects next

-93.2%

ROA-48.2%

Growth

Beta3.25